Catarina Lobo Santos de Souza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Catarina Lobo Santos de Souza has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Afonso Celso Vigorito
Universidade Estadual de Campinas – Campinas (SP), Brazil
1 shared publication - Alessandro de Moura Almeida
Hospital Universitário Professor Edgar Santos, Federal University of Bahia, Hematology and Hemotherapy Department, Salvador, Brazil
1 shared publication - Alexandre de Almeida Candolo
Hospital de Câncer de Barretos, Barretos , SP , Brazil
1 shared publication - Ana Carolina Leão Silva
Molecular Oncology and Viral Pathology Group, IPO Porto Research Centre (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)/Department of Pathology and Laboratory Medicine/RISE-Associate Laboratory (Health Research Network)/Porto Comprehensive Cancer Centre Raquel Seruca (Porto.CCC), 4200-072 Porto, Portugal
1 shared publication - Ana Elisa de Paula Brandão-Anjos
Fundação Hospital Amaral Carvalho , Jaú , SP , Brazil
1 shared publication - Andrea Z. Pereira
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 May 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (5) , 484
Prognostic value of nutritional and functional screening instruments for mortality in patients with hematologic malignancies
Purpose: Functional and nutritional impairments adversely affect outcomes in hematologic malignancies; however, the comparative prognostic value of widely available screening instruments remains insufficiently explored. The present study aimed to examine the association between nutritional and functional screening instruments and 12-month mortality in hospitalized patients with hematologic malignancies. Methods: In this prospective cohort of 91 patients (median age 53 years [IQR, 35–61]), nutritional screening and assessment tools (PG-SGA, GLIM criteria) and functional screening instruments (SARC-F, SARC-CalF, and Geriatric 8 [G8]) were applied within 72 h of admission. The G8 was pragmatically used as a multidimensional vulnerability screening instrument. Discriminative ability for mortality was evaluated using ROC curve analysis, and Cox regression models (unadjusted and adjusted) were used to examine associations with mortality. Results: During follow-up, 29.7% of patients died. The G8 and SARC-CalF were associated with mortality in adjusted models (HR 4.83, 95% CI 1.13–20.68; HR 2.37, 95% CI 1.08–5.17, respectively). PG-SGA Global showed acceptable discriminative performance in ROC analyses (AUC 0.71) but was not associated with mortality after adjustment. GLIM criteria were not associated with mortality in adjusted models. Conclusion: The G8 and SARC-CalF scores have demonstrated prognostic utility as simple and low-cost screening tools associated with mortality in these patients with hematological malignancies hospitalized in a resource-limited service.
- 1 May 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (5) , 484
Open AccessPrognostic value of nutritional and functional screening instruments for mortality in patients with hematologic malignancies
Purpose: Functional and nutritional impairments adversely affect outcomes in hematologic malignancies; however, the comparative prognostic value of widely available screening instruments remains insufficiently explored. The present study aimed to examine the association between nutritional and functional screening instruments and 12-month mortality in hospitalized patients with hematologic malignancies. Methods: In this prospective cohort of 91 patients (median age 53 years [IQR, 35–61]), nutritional screening and assessment tools (PG-SGA, GLIM criteria) and functional screening instruments (SARC-F, SARC-CalF, and Geriatric 8 [G8]) were applied within 72 h of admission. The G8 was pragmatically used as a multidimensional vulnerability screening instrument. Discriminative ability for mortality was evaluated using ROC curve analysis, and Cox regression models (unadjusted and adjusted) were used to examine associations with mortality. Results: During follow-up, 29.7% of patients died. The G8 and SARC-CalF were associated with mortality in adjusted models (HR 4.83, 95% CI 1.13–20.68; HR 2.37, 95% CI 1.08–5.17, respectively). PG-SGA Global showed acceptable discriminative performance in ROC analyses (AUC 0.71) but was not associated with mortality after adjustment. GLIM criteria were not associated with mortality in adjusted models. Conclusion: The G8 and SARC-CalF scores have demonstrated prognostic utility as simple and low-cost screening tools associated with mortality in these patients with hematological malignancies hospitalized in a resource-limited service.
- Open Access
- 13 March 2020
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 18, eAE4799
Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease
The Brazilian Consensus on Nutrition in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease was approved by Sociedade Brasileira de Transplante de Medula Óssea , with the participation of 26 Brazilian hematopoietic stem cell transplantation centers. It describes the main nutritional protocols in cases of Graft- versus -host disease, the main complication of hematopoietic stem cell transplantation.
- 13 March 2020
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 18, eAE4799
Open AccessBrazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease
The Brazilian Consensus on Nutrition in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease was approved by Sociedade Brasileira de Transplante de Medula Óssea , with the participation of 26 Brazilian hematopoietic stem cell transplantation centers. It describes the main nutritional protocols in cases of Graft- versus -host disease, the main complication of hematopoietic stem cell transplantation.